Search for: [Abstract = "oints together. We designed a randomized, double\-blinded 12\-week trial. All participants were randomly assigned to receive either fluoxetine \(treatment\) or placebo \(control\). Out of 100 patients enrolled in the study, 48 were randomized to control and 52 to treatment group. 79 patients have completed the study \(treatment, n=45\; control, n=34\). After randomization and before medication, each woman was asked to complete the Green Climacteric Scale and MRS scale as well as undergo anthropometric measurements such as circumferences of hips and waist, weight and one blood test. Identical questionnaires and measurements were conducted during follow\-up visits 4, 8 and 12 weeks after initiating treatment. The women were asked to write down potential adverse effects. The subjects were asked not to change their lifestyle, or take on new excessive exercise programs or diet. Diet was not an intended co\-intervention during this examination. The results has undergone statistical analysis. Comparison of both groups regarding the influence of fluoxetine and placebo on body mass in the course of the study In case of patients’ body mass the variables of time \(p<0,001\) and interaction with method of treatment \(p<0,001\) have proved to be statistically significant. In case of the group treated with fluoxetine significant body mass loss occurred already in the beginning of treatment \(p<0,00"]

Number of results: 1